These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17015904)

  • 1. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
    Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
    J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line].
    Chen J; Liu T; Zhe X; Jiang J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Jun; 21(3):197-202. PubMed ID: 12569653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors.
    Flickinger KS; Judware R; Lechner R; Carter WG; Culp LA
    Exp Cell Res; 1994 Jul; 213(1):156-63. PubMed ID: 8020586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of hybridization of mRNA of c-myc oncogene with 111In-labeled antisense oligodeoxynucleotide probes by high-pressure liquid chromatography.
    Dewanjee MK; Ghafouripour AK; Kapadvanjwala M; Samy AT
    Biotechniques; 1994 May; 16(5):844-6, 848, 850. PubMed ID: 8068339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice.
    Sleight BJ; Soukup S; Ballard ET; Parysek LM
    Anticancer Res; 1993; 13(6A):2031-6. PubMed ID: 8297111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumor model.
    Sekhon HS; London CA; Sekhon M; Iversen PL; Devi GR
    Lung Cancer; 2008 Jun; 60(3):347-54. PubMed ID: 18096271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of translation initiation region of c-myc mRNA and thermostability of the c-myc mRNA/antisense ODN complex.
    Tanaka T; Kurihara Y; Sakamoto T; Furusawa M; Kobayashi A; Katahira M; Takeuchi K; Sugimoto N; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):135-6. PubMed ID: 8841589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense suppression of N-myc expression inhibits the transdifferentiation of neuroectoderm tumor cell lines.
    Whitesell L; Rosolen A; Neckers LM
    Prog Clin Biol Res; 1991; 366():45-54. PubMed ID: 2068159
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
    Fonge H; Lee H; Reilly RM; Allen C
    Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
    Takei Y; Kadomatsu K; Matsuo S; Itoh H; Nakazawa K; Kubota S; Muramatsu T
    Cancer Res; 2001 Dec; 61(23):8486-91. PubMed ID: 11731432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeting delivery effect of galactose receptor-mediated c-myc antisense oligonucleotide on human hepatocellular carcinoma cell line Bel-7402].
    Jiang JW; Zhang Y
    Ai Zheng; 2004 Nov; 23(11):1288-93. PubMed ID: 15522175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.
    Liu X; Wang Y; Nakamura K; Kawauchi S; Akalin A; Cheng D; Chen L; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2009 Apr; 50(4):582-90. PubMed ID: 19289423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabeling of avidin with very high specific activity for internal radiation therapy of intraperitoneally disseminated tumors.
    Mamede M; Saga T; Kobayashi H; Ishimori T; Higashi T; Sato N; Brechbiel MW; Konishi J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3756-62. PubMed ID: 14506168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting and imaging of intraperitoneal tumors by use of antisense oligo-DNA complexed with dendrimers and/or avidin in mice.
    Sato N; Kobayashi H; Saga T; Nakamoto Y; Ishimori T; Togashi K; Fujibayashi Y; Konishi J; Brechbiel MW
    Clin Cancer Res; 2001 Nov; 7(11):3606-12. PubMed ID: 11705883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ; Tenhunen M; Jekunen AP
    Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.